粘液塞作为COPD患者恶化和肺功能下降的前体
Kwang Nam Jin1, Hyo Jin Lee2, Heemoon Park2
1Department of Radiology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Republic of Korea.
Archivos de bronconeumologia
|August 9, 2024
概括
慢性阻塞性肺病 (COPD) 中的粘液塞预测在五年内更频繁的恶化和更快的肺功能下降. 在CT扫描中识别粘液塞有助于预测COPD进展和恶化风险.
科学领域:
- 肺部医学 肺部医学
- 放射学 放射学是一门学科.
- 呼吸系统研究 呼吸系统研究
背景情况:
- 胸部CT扫描中的粘液塞正在成为COPD潜在的预后指标.
- 这项研究调查了粘液塞对COPD恶化和FEV1下降的5年影响.
研究的目的:
- 评估粘液塞和COPD患者恶化风险之间的关联.
- 评估粘液塞对FEV1下降率在5年期间的影响.
- 确定粘液塞在预测COPD进展中的预后价值.
主要方法:
- 一项为期5年的纵向研究,涉及COPD患者的基线胸部CT和螺旋计.
- 根据粘液塞的存在来对患者进行分类,倾向性得分匹配创造了平衡的群体.
- 分析了恶化率,恶化时间,危险比率和年度FEV1下降,基于粘液塞得分的灵敏度分析.
主要成果:
- 在623名COPD患者中,有44.3%患有粘液塞;匹配组 (每组n=187) 证实中度至重度,重度和非eosinophilic恶化的发病率更高.
- 粘液塞显著增加了中度至重度 (aHR=1.502),重度 (aHR=2.106) 和非酸性恶化 (aHR=1.551) 的危险.
- 在粘液塞组 (β=-62;P=0.035) 观察到加速的年度FEV1下降,粘液塞得分≥3.3的风险较高.
结论:
- 粘液塞与恶化风险的增加显著相关,特别是非乙酸性恶化风险,并加快了COPD患者在5年内FEV1的下降.
- 在CT扫描中发现的粘液塞的存在和严重程度对未来的恶化风险和COPD肺功能下降轨迹具有预后价值.
更多相关视频
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:20COPD: Pathogenesis and Clinical Features
248
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
248
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:16Drugs Used in Upper Respiratory Disorders: Overview
199
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
199
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K